▲ SIGMATERMINAL Open Terminal →

Analyses / ROP

ROP Roper Technologies Inc As of Jul 24, 2026
$355.12

Large-cap diversified industrial software & equipment play. Recent earnings beat; valuation elevated but justified by margin quality.

Setup: quality_growth Confidence: 68 Horizon: 6-12 months Risk: medium Category: Large Cap
🔒 Trade Plan — entry · target · stop
Entry Zone
$•••–•••
Target
$•••
Stop Loss
$•••
Risk / Reward
•.• : 1
Unlock the exact levels — free →

A free account reveals ROP's entry zone, price target & stop loss. Full 1-week to 1-year price forecasts are included with Pro.

The Thesis

▲ Bull Case

Strong Q2 earnings beat with raised guidance. Consistent 5-yr revenue CAGR of 14.46%, operating margins of 28.3%, and price-to-FCF of 14.8x signal operational excellence. Insider buys (28 vs 18 sells) + 1.08% dividend yield on stable cash flow. Industrial sector sentiment constructive.

▼ Bear Case

Forward P/E of 23.5x and EV/EBITDA of 21.8x trade rich vs historical; recent -30.6% YoY EPS decline suggests near-term earnings pressure despite revenue growth. Low current/quick ratios (0.52/0.48) signal liquidity tightness. Stock down ~37% from 52-week high ($566), leaving room for further consolidation.

Valuation

FAIRLY VALUED to PREMIUM — score 58/100

P/E 21.1x and forward P/E 23.5x sit at historical median for quality industrials but trade rich vs cyclical peers. Price-to-FCF 14.8x and P/S 4.6x support premium, justified by 28.3% operating margin and 5-yr 14.5% revenue CAGR. However, -30.6% YoY EPS decline flags near-term earnings pressure.

Technical Levels

Support · $336.71 (Recent Close (Previous)) · $330.00 (Emerging Support (3-month trend)) · $305.96 (52-Week Low)

Resistance · $369.15 (Today's High) · $395.00 (Target / Resistance Cluster) · $450.00 (Bull Target (prior support zone)) · $566.24 (52-Week High)

RSI: Not provided

Financial Health

Score 68/100. Balance sheet shows operational strength (excellent margins) offset by tight liquidity ratios. Low payout ratio + strong FCF generation suggest ability to weather near-term working capital tightness. No red flags if cash conversion cycle remains stable. Monitor Q3 cash flow report.

Catalysts

Q3 2026 Earnings (est. Oct–Nov)~8 weeksKEY — Will confirm EPS stabilization path and margin recovery. Beat likely re-rates P/E up 1–2 turns; miss could reset to 19x.
Full-Year Guidance Raise / MaintainNext earnings callHIGH — Management credibility hinge. Raise supports bull case; cut triggers 5–10% pullback.
Application Software M&A / Organic Growth UpdateOngoing / investor day (if held)MEDIUM — This segment is growth engine; any acceleration or deceleration signals execution.
Macro / Fed Rate Path RevisionOngoing (FOMC meetings Dec, 2025)MEDIUM — Industrial conglomerates sensitive to rate/growth outlook. Pivot to cuts could lift multiples; hold/cuts could compress.

Risk Flags

EPS down 30.6% YoY despite revenue +13.7%; profitability margin compression warrants monitoring.
Current/quick ratios below 0.5; liquidity metrics tighter than peers; monitor working capital trends.
Stock 37% below 52-week high; technical consolidation may persist before new highs.
Forward P/E of 23.5x assumes earnings recovery; miss or guidance cut risks repricing.
Finnhub sentiment/RSI/ROE/ROIC unavailable; full fundamental depth limited by data gaps.

See ROP's full trade plan — free

Create a free account to unlock the exact entry, target, and stop — plus run live analysis on any of 5,000+ tickers. No card required.

Unlock ROP free →

Recent News

More Analyses

ROP FAQ

Is ROP a buy right now?

Roper Technologies Inc's current read is a quality_growth setup with 68 confidence over a 6-12 months horizon. Valuation: FAIRLY VALUED to PREMIUM. See the full bull and bear case above, or run a live analysis for the exact entry, target and stop.

Is ROP overvalued?

FAIRLY VALUED to PREMIUM (valuation score 58/100). P/E 21.1x and forward P/E 23.5x sit at historical median for quality industrials but trade rich vs cyclical peers. Price-to-FCF 14.8x and P/S 4.6x support premium, justified by 28.3% operating margin and 5-yr 14.5% revenue CAGR. However, -30.6% YoY EPS decline flags near-term earnings pressure.

What are the risks of buying ROP?

Forward P/E of 23.5x and EV/EBITDA of 21.8x trade rich vs historical; recent -30.6% YoY EPS decline suggests near-term earnings pressure despite revenue growth. Low current/quick ratios (0.52/0.48) signal liquidity tightness. Stock down ~37% from 52-week high ($566), leaving room for further consolidation.